EMA Authorised: Vokanamet (canagliflozin;metformin hydrochloride) — Janssen-Cilag International NV

View source ↗

Summary

The EMA authorised Vokanamet, a fixed-dose combination tablet of canagliflozin and metformin hydrochloride, for type 2 diabetes mellitus; marketing authorizatio…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Vokanamet (canagliflozin)

Snippet

Status: Authorised. Therapeutic area: Diabetes Mellitus, Type 2. MAH: Janssen-Cilag International NV. Decision date: 10/06/2025